Prolifix Overview

  • Year Founded
  • 1994

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 1

Employees

  • Latest Deal Type
  • M&A

Prolifix General Information

Description

Researcher and developer of novel drugs for the treatment of proliferative diseases. The company focuses on molecular processes to regulate the growth and division of cells to discover drugs for alleviate proliferative disease characterised by uncontrolled cell growth.

Contact Information

Formerly Known As
Secretpurpose Limited
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 91 Milton Park
  • Oxfordshire
  • Abingdon OX14 4RY
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 91 Milton Park
  • Oxfordshire
  • Abingdon OX14 4RY
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Prolifix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 04-Jun-2002 Completed Generating Revenue
4. Later Stage VC 18-Oct-1999 Completed Generating Revenue
3. Early Stage VC 09-Jun-1997 Completed Startup
2. Early Stage VC 01-Dec-1995 $7.83M $7.83M Completed Startup
1. Seed Round 01-Nov-1994 Completed Startup
To view Prolifix’s complete valuation and funding history, request access »

Prolifix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Prolifix Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
3i Corporation Minority
Atlas Venture Venture Capital Minority
Chugai Pharmaceuticals Corporation Minority
Gimv PE/Buyout Minority
HealthCap Venture Capital Minority
To view Prolifix’s complete investors history, request access »

Prolifix FAQs

  • When was Prolifix founded?

    Prolifix was founded in 1994.

  • Where is Prolifix headquartered?

    Prolifix is headquartered in Abingdon, United Kingdom.

  • What is the size of Prolifix?

    Prolifix has 1 total employees.

  • What industry is Prolifix in?

    Prolifix’s primary industry is Drug Discovery.

  • Is Prolifix a private or public company?

    Prolifix is a Private company.

  • What is Prolifix’s current revenue?

    The current revenue for Prolifix is .

  • How much funding has Prolifix raised over time?

    Prolifix has raised $23.4M.

  • Who are Prolifix’s investors?

    3i, Atlas Venture, Chugai Pharmaceuticals, Gimv, and HealthCap have invested in Prolifix.

  • When was Prolifix acquired?

    Prolifix was acquired on 04-Jun-2002.

  • Who acquired Prolifix?

    Prolifix was acquired by Topotarget.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process